Indian equities tracking gains in the global market ended in the green amid broad-based buying. Nifty ended 0.6 per cent higher at 19,638, while Sensex advanced 0.5 per cent to close at 65,828. Sectorally, pharma, healthcare and metal stocks led the rally, while the IT pack emerged as the laggard after Accenture predicted a gloomy year considering muted spending.

Here are the top stocks that were in focus all through the trading session on Friday, September 29, 2023.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Eris Lifesciences: Shares of the drug maker hit a fresh 52-week high in intra-day trade at Rs 925, gaining around 9 per cent over the previous close. Sharp gains in the counter were amid a spurt in trading volume by more than 24 times.

Aurobindo Pharma: Shares of the Hyderabad-based pharma major ended with gains of over 4 per cent at Rs 914.20 per share on the BSE after scaling a 52-week high at Rs 930 in intraday trade. The gains in the stock came after sources revealed that the company had received approval for launching the Revlimid drug.

Ajmera Realty: Shares of the real estate player ended with gains of around 6 per cent at Rs 380.1 apiece on the BSE after the company secured two residential projects with a gross development value of Rs 470 crore.

Khadim India: The footwear company’s shares settled in the green with gains of over 4 per cent at Rs 321 after the company’s board approved the demerger of its distribution segment.

Also Read: Aditya Birla Finance's NCD issue is open for subscription: Key things to know

Saregama India: Shares of the media and entertainment company surged by as much as 6.5 per cent to touch the day’s high of Rs 393.35 on acquiring Pocket Aces, the leading digital entertainment start-up. Nevertheless, at the close, the stock ended in the red, down by around 1 per cent at Rs 366.

Hindustan Zinc: Shares of the company ended with gains of over 3 per cent at Rs 308 after the company, in its board meeting held today, authorised the Committee of Directors (CoD) to assess appropriate corporate restructuring measures to unlock shareholder value.

Lupin: Shares of the leading drug player rallied over 3 per cent to settle at Rs 1,172 per share on the BSE. The gains in the stock were seen after the company, in an exchange filing, said that it had received an EIR, or Establishment Inspection Report, for its Nagpur Unit-1 manufacturing facility from the US FDA.

3M India: Shares of the company advanced and ended over 2 per cent higher at Rs 31,611 after the company slashed the royalty payable to its parent companies to 1.95 per cent.

Navin Fluorine: Shares of the chemicals company nosedived as much as 15 per cent to touch a 52-week low of Rs 3,729 per share. The sharp losses in the stock came after the company’s MD, Radhesh Ratnakar Welling, resigned from the position.

Ashok Leyland: Shares of the commercial vehicle major ended around 2 per cent higher at Rs 177 as the company bagged orders for 1,282 buses from Gujarat State Road Transport Corporation.

Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.